[Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHémaP].

Aim: Assessment of the impact of guidelines from a regional pediatric network to standardize the management of childhood immune thrombocytopenic purpura (ITP).

Materials And Methods: Consensus guidelines were drawn up in centers of the pediatric network for hematological diseases, RHémaP, and a cohort of children referred for ITP in these centers was set up. A 1-year follow-up was recorded for each patient over a 43-month period.